Celldex Therapeutics, Inc. (CLDX)

Celldex Therapeutics Revenue

In the year 2023, Celldex Therapeutics had annual revenue of $6.88M with 192.02% growth. Revenue in the quarter ending December 31, 2023 was $4.13M with 156.11% year-over-year growth.

• Revenue (ttm): $6.88M
• Revenue Growth: +192.02%
• P/S Ratio: 407.55
• Revenue / Employee: $43,019
• Employees: 160
• Market Cap: 2.81B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	6.88M	4.53M	192.02%
Dec 31, 2022	2.36M	-2.29M	-49.32%
Dec 31, 2021	4.65M	-2.77M	-37.30%
Dec 31, 2020	7.42M	3.85M	107.61%
Dec 31, 2019	3.57M	-5.97M	-62.54%
Dec 31, 2018	9.54M	-3.21M	-25.15%
Dec 31, 2017	12.74M	5.96M	87.78%
Dec 31, 2016	6.79M	1.31M	23.83%
Dec 31, 2015	5.48M	1.89M	52.82%
Dec 31, 2014	3.59M	-525.00K	-12.77%
Dec 31, 2013	4.11M	-7.09M	-63.30%
Dec 31, 2012	11.20M	1.94M	20.91%
Dec 31, 2011	9.27M	-37.53M	-80.20%
Dec 31, 2010	46.79M	31.61M	208.25%
Dec 31, 2009	15.18M	7.72M	103.59%
Dec 31, 2008	7.46M	6.05M	430.30%
Dec 31, 2007	1.41M	506.82K	56.36%
Dec 31, 2006	899.18K	-2.19M	-70.88%
Dec 31, 2005	3.09M	-3.77M	-54.97%
Dec 31, 2004	6.86M	2.23M	48.04%
Dec 31, 2003	4.63M	-2.07M	-30.90%
Dec 31, 2002	6.70M	3.36M	100.39%
Dec 31, 2001	3.35M	2.58M	338.40%
Dec 31, 2000	763.20K	-720.30K	-48.55%
Dec 31, 1999	1.48M	-666.90K	-31.01%
Dec 31, 1998	2.15M	958.30K	80.39%
Dec 31, 1997	1.19M	77.60K	6.96%
Dec 31, 1996	1.11M	-2.85M	-71.88%
Dec 31, 1995	3.96M	-3.00M	-43.12%
Dec 31, 1994	6.97M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.